Serda Therapeutics
Developer of enzymatic wound debridement product for burns and ulcers.
1
Funding Rounds
$2.2m
Money raised
Overview
Developer of enzymatic wound debridement product for burns and ulcers.
- Website:
- Business model: B2C
- Headquarters: Amsterdam
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Serda Therapeutics has raised a total of $2.2m in funding over 1 rounds.
Key Insights:
- Serda Therapeutics June 2024 Seed Funding Round: $2.2m
Serda Therapeutics June 2024 Seed Funding Round
$2.2m
Industries
Serda Therapeutics is active in the following industries: